Brain cancers, including glioblastoma, oligodendroglia, anaplastic astrocytoma, diffuse astrocytoma, and glioblastoma, show a significant reduction of cacna1b expression compared to the control groups [55]. This evidence concerns the gene CACNA1B and brain cancer.